NCT04050215View on ClinicalTrials.gov

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

937

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate AdenocarcinomaProstate CarcinomaPSA Level Greater Than FiftyPSA ProgressionStage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Gallium Ga 68-labeled PSMA-11

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT04050215 - 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter